R Röder
Therapy of early poststroke depression with venlafaxine: safety, tolerability, and efficacy as determined in an open, uncontrolled clinical trial
Dahmen N, Marx J, Hopf H, Tettenborn B, Röder R. Therapy of early poststroke depression with venlafaxine: safety, tolerability, and efficacy as determined in an open, uncontrolled clinical trial. Stroke 1999; 30:691-2.
Mar 1, 1999Therapy of early poststroke depression with venlafaxine: safety, tolerability, and efficacy as determined in an open, uncontrolled clinical trial
Mar 1, 1999Stroke 1999; 30:691-2
Dahmen N, Marx J, Hopf H C, Tettenborn Barbara, Röder R
Behandlung der frühen Post-Stroke-Depression mit Venlafaxin: Sicherheit, Verträglichkeit und Wirksamkeit in einer offenen klinischen Studie
Tettenborn B, Dahmen N, Marx J, Hopf H, Röder R. Behandlung der frühen Post-Stroke-Depression mit Venlafaxin: Sicherheit, Verträglichkeit und Wirksamkeit in einer offenen klinischen Studie. Neurologische Rehabilitation 1999; 5:85-9.
Jan 1, 1999Behandlung der frühen Post-Stroke-Depression mit Venlafaxin: Sicherheit, Verträglichkeit und Wirksamkeit in einer offenen klinischen Studie
Jan 1, 1999Neurologische Rehabilitation 1999; 5:85-9
Tettenborn Barbara, Dahmen N, Marx J, Hopf HC, Röder R
Therapy of early post stroke depression with venlafixine: safety, tolerability and efficacy as determined in an open, uncontrolled clinical trial
Tettenborn B, Dahmen N, Marx J, Hopf H, Röder R. Therapy of early post stroke depression with venlafixine: safety, tolerability and efficacy as determined in an open, uncontrolled clinical trial. Stroke 1999; 30:691-2.
Jan 1, 1999Therapy of early post stroke depression with venlafixine: safety, tolerability and efficacy as determined in an open, uncontrolled clinical trial
Jan 1, 1999Stroke 1999; 30:691-2
Tettenborn Barbara, Dahmen N, Marx J, Hopf HC, Röder R